Cambridge GaN Devices (CGD), a spin off from the Cambridge University, is a fabless semiconductor company on a mission to shape the future of power electronics by delivering the most efficient and easy-to-use transistor. 

Cambridge GaN Devices develops transistors designed to bring widespread adoption of GaN technology in consumer electronics.

Cambridge GaN Devices was founded in 2016 by Prof. Florin Udrea and Dr. Giorgia Longobardi. The company is headquartered in Cambridge, UK.

CGD introduced ICeGaN™ - an industry-first enhancement-mode (eMode) GaN transistor which can be operated like a Silicon MOSFET without the need for special gate drivers, driving circuitry, or unique gate voltage clamping mechanisms.

CGD's ICeGaN™ Gallium Nitride transistor family which addresses a $50bn global power semiconductor market. CGD technology is protected by a strong IP portfolio that constantly grows based on the company's leading innovation skills and ambitions.

CGD is currently leading a $10m European-funded project developing GaN-based modules for low and high-power applications (GaNext). The company also secured three other projects funded by iUK, BEIS and EU (Penta).

CGD is backed by IQ Capital, Parkwalk Advisors, BGF Ventures, CIC, Foresight Williams Technology, Cambridge Enterprise, Martlet Capital, and others. The company raised $19M in Series B round on Nov 15, 2022. This brings CGD's total funding to $28.5M to date.